Maine Cancer Action Center

For the second year in a row, legislation to increase access to biomarker testing has failed to pass in the final days of legislative activity.

By ensuring more Mainers have biomarker testing covered by their insurance plans, we can increase access to personalized medicine and realize better outcomes for cancer patients as well other disease groups. It's time for Gov. Mills to act to make this a reality.

Nation’s Leading Cancer Advocacy Organization Urges Support of LD2028 Minority Report to Protect Public Health

AUGUSTA, ME – JANUARY 29, 2024 – On Tuesday, January 30, Maine’s Joint Standing Committee on Health Coverage, Insurance and Financial Services will consider LD 1577. The American Cancer Society Cancer Action Network (ACS CAN) urges Committee members to support the bill, which aims to expand coverage for biomarker testing—when